Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Joseph Saseen to Angiotensin-Converting Enzyme Inhibitors

This is a "connection" page, showing publications Joseph Saseen has written about Angiotensin-Converting Enzyme Inhibitors.

 
Connection Strength
 
 
 
0.699
 
  1. Sontheimer D, Hitchcock K, Saseen J. Clinical inquiries. Are there big differences among beta-blockers in treating essential hypertension? J Fam Pract. 2007 Apr; 56(4):312-4.
    View in: PubMed
    Score: 0.245
  2. Sferra L, Kelsberg G, Dodson S, Saseen J. Clinical inquiries. Do ACE inhibitors prevent nephropathy in type 2 diabetes without proteinuria? J Fam Pract. 2004 Jan; 53(1):68-9.
    View in: PubMed
    Score: 0.195
  3. Saseen JJ, MacLaughlin EJ, Westfall JM. Treatment of uncomplicated hypertension: are ACE inhibitors and calcium channel blockers as effective as diuretics and beta-blockers? J Am Board Fam Pract. 2003 Mar-Apr; 16(2):156-64.
    View in: PubMed
    Score: 0.184
  4. Saseen JJ, Turner C, Russell RG. Clinical inquiries. What is the best regimen for newly diagnosed hypertension? J Fam Pract. 2005 Mar; 54(3):281-2.
    View in: PubMed
    Score: 0.053
  5. Hanselin MR, Saseen JJ, Allen RR, Marrs JC, Nair KV. Description of antihypertensive use in patients with resistant hypertension prescribed four or more agents. Hypertension. 2011 Dec; 58(6):1008-13.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)